Culture-free sequencing recovers TB genetic variation

Tuberculosis (TB) bacteria can be hard to study directly from patient samples because clinical material contains many different DNAs and organisms. Katharine S. Walter and colleagues set out to test whether a culture-free approach—hybrid capture of bacterial DNA from complex clinical specimens—could reliably recover Mycobacterium tuberculosis genomic information. The team noted that, although it is possible to obtain DNA from such samples, the accuracy of identifying genetic variants from captured material had not been systematically evaluated. Their work focused on whether hybrid capture could identify the same fixed and minority genetic variants as traditional culture-based sequencing, and on how contamination and other practical challenges might affect those calls. The study compares matched diagnostic samples processed by culture and by hybrid capture to assess how well the culture-free method reproduces the genetic picture of the infecting bacteria.

To compare the two approaches, the researchers examined the number, identity, and minor allele frequencies of minority variants found in cultured versus hybrid captured diagnostic samples. They found that contamination was a real issue in captured samples, accounting for more than 25% of sequence reads in some cases. Despite that, there was no statistically significant difference in the number of minority variants detected: cultured samples had a median of 14 variants (range 9–23), while hybrid captured samples had a median of 22 variants (range 4–328), with p = 0.2. Importantly, the minor allele frequencies measured in the two methods were highly correlated (r = 0.95, p < 0.001). The authors conclude that hybrid capture can produce whole genome sequences and minority variant calls that are comparable to culture-based sequencing.

The findings suggest that hybrid capture could be a viable culture-free alternative for recovering M. tuberculosis genomic variation from clinical samples. Because the method produced comparable minority variant calls and strongly correlated allele frequencies with cultured isolates, it may let researchers include specimens that fail to grow in culture or are difficult to culture, potentially broadening the range of samples available for genomic studies. At the same time, the observed contamination underscores the need for careful laboratory practices and further optimization of capture protocols. Overall, Katharine S. Walter and her team propose that hybrid capture may extend the coverage of genomic epidemiology studies, offering another tool for tracking TB diversity and transmission when culture is not feasible.